Andere Sprachen Humacyte, Inc.

Aktien

A3CZBW

US44486Q1031

HUMA

Realtime-Estimate Cboe BZX Andere Börsenplätze 17:35:21 29.05.2024			% 5 Tage	% 1. Jan.
7,7 ^USD	+2,80 %		+1,46 %	+170,07 %

10.05.	Transcript : Humacyte, Inc., Q1 2024 Earnings Call, May 10, 2024
28.03.	Transcript : Humacyte, Inc. - Special Call

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Humacyte First Quarter 2024 Financial Results and Business Update	13.05.
Humacyte to Participate at Upcoming Investor Conferences in May	13.05.
Humacyte First Quarter 2024 Financial Results and Business Update	10.05.
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024	06.05.
Humacyte to Host Virtual KOL Event Hemodialysis Access, a Crossroads of Care, on March 28, 2024	27.03.
Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024	26.03.
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update	25.03.
Interest Rate, Monetary Policy Views Lift Wall Street Pre-Bell; Asia Mixed, Europe Up	22.03.
Humacyte, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22.03.
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update	22.03.
Humacyte, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22.03.
North American Morning Briefing : Stocks Struggle After New Records	22.03.
Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024	18.03.
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference	04.03.
Humacyte Announces Proposed Public Offering of Common Stock	01.03.
Sector Update: Health Care Stocks Edge Higher Premarket Friday	01.03.
Investors Await Key Economic Data, Markets Remain Flat Ahead of Opening Bell	01.03.
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference	01.03.
Humacyte Prices $40.2 Million Share Offering	01.03.
Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock	01.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Humacyte, Inc.

Aktien

A3CZBW

US44486Q1031

HUMA

Andere Sprachen

Filter